- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes ; volume:16 ; number:1 ; day:2 ; month:2 ; year:2017 ; pages:1-12 ; date:12.2017
Cardiovascular diabetology ; 16, Heft 1 (2.2.2017), 1-12, 12.2017
- Schlagwort
-
Endokrinologie
- Urheber
-
Xu, James
- Beteiligte Personen und Organisationen
-
Rajaratnam, Rohan
SpringerLink (Online service)
- DOI
-
10.1186/s12933-017-0499-5
- URN
-
urn:nbn:de:1111-201702263197
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, James
- Rajaratnam, Rohan
- SpringerLink (Online service)
Ähnliche Objekte (12)
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy
Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
Kohlenhydratstoffwechsel, Insulin und Diabetes
Rhinitis: immunopathology and pharmacotherapy
Pharmacotherapy of gastrointestinal inflammation
Pharmacotherapy of pulmonary hypertension
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy
Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
Kohlenhydratstoffwechsel, Insulin und Diabetes
Rhinitis: immunopathology and pharmacotherapy
Pharmacotherapy of gastrointestinal inflammation
Pharmacotherapy of pulmonary hypertension
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy
Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk : The ODYSSEY DM-INSULIN randomized trial
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
Kohlenhydratstoffwechsel, Insulin und Diabetes
Rhinitis: immunopathology and pharmacotherapy
Pharmacotherapy of gastrointestinal inflammation